tumorsMalignant tumoursMalignant tumours2224-50572587-6813Rosoncoweb10.18027/2224-5057-2025-058tumors-1598Research ArticleКОНСЕНСУСCONSENSUSРоссийский консенсус по профилактике, диагностике и лечению рака желудка. Вопросы хирургического леченияRussian consensus on prevention, diagnosis and treatment of gastric cancer. Issues of surgical treatmenthttps://orcid.org/0000-0002-4088-8118ХатьковИ. В.KhatkovI. E.

Хатьков Игорь Евгеньевич

111123 Москва, Новогиреевская ул., 1, корп. 1

Khatkov Igor Evgenievich

 Build. 1, 1 Novogireevskaya St., Moscow 111123 

https://orcid.org/0000-0001-9116-9693ВасневО. С.VasnevO. S.

Васнев Олег Сергеевич

111123 Москва, Новогиреевская ул., 1, корп. 1

Vasnev Oleg Sergeevich

 Build. 1, 1 Novogireevskaya St., Moscow 111123 

https://orcid.org/0000-0001-7254-5411ИзраиловР. Е.IzrailovR. E.

Израилов Роман Евгеньевич

111123 Москва, Новогиреевская ул., 1, корп. 1

Izrailov Roman Evgenievich

Build. 1, 1 Novogireevskaya St., Moscow 111123 

https://orcid.org/0000-0001-7457-3889КалининА. Е.KalininA. E.

Калинин Алексей Евгеньевич

115478 Москва, Каширское шоссе, 23

Kalinin Alexey Evgenievich

 23 Kashirskoe Shosse, Moscow 115478 

https://orcid.org/0000-0001-6641-7229КарачунА. М.KarachunA. M.

Карачун Алексей Михайлович

197758 Санкт-Петербург, п. Песочный, ул. Ленинградская, 68

Karachun Alexey Mikhailovich

 68 Leningradskaya St., Pesochnyy, Saint Petersburg 197758 

https://orcid.org/0000-0002-4958-5850КащенкоВ. А.KashchenkoV. A.

Кащенко Виктор Анатольевич

194291 Санкт-Петербург, пр. Культуры, 4

Kashchenko Viktor Anatolyevich

4 Kultury Pr., Saint Petersburg 194291 

https://orcid.org/0000-0003-4744-6141КононецП. В.KononetsP. V.

Кононец Павел Вячеславович

115478 Москва, Каширское шоссе, 23

 Kononets Pavel Vyacheslavovich 

 23 Kashirskoe Shosse, Moscow 115478 

https://orcid.org/0000-0002-7281-3591ЛядовВ. К.LyadovV. K.

Лядов Владимир Константинович

117152 Москва, Загородное шоссе, 18А

 Lyadov Vladimir Konstantinovich 

18A Zagorodnoe Shosse, Moscow 117152 

https://orcid.org/0000-0002-8801-4903МатвейчукД. А.MatveychukD. А.

Матвейчук Данила Алексеевич

111123 Москва, Новогиреевская ул., 1, корп. 1

 Matveychuk Danila Alekseevich 

 Build. 1, 1 Novogireevskaya St., Moscow 111123 

https://orcid.org/0000-0003-2647-4362НедолужкоИ. Ю.NedoluzhkoI. Yu.

Недолужко Иван Юрьевич

111123 Москва, Новогиреевская ул., 1, корп. 1

 Nedoluzhko Ivan Yurievich 

 Build. 1, 1 Novogireevskaya St., Moscow 111123 

https://orcid.org/0000-0001-5543-199XСеменовН. Е.SemenovN. E.

Семенов Николай Евгеньевич

111123 Москва, Новогиреевская ул., 1, корп. 1

Semenov Nikolay Evgenievich 

Build. 1, 1 Novogireevskaya St., Moscow 111123 

n.semenov@mknc.ruhttps://orcid.org/0000-0002-5229-8203СтилидиИ. С.StilidiI. S.

Стилиди Иван Сократович

115478 Москва, Каширское шоссе, 23

Stilidi Ivan Sokratovich 

23 Kashirskoe Shosse, Moscow 115478 

https://orcid.org/0000-0001-8301-4528ХомяковВ. М.KhomyakovV. M.

Хомяков Владимир Михайлов

125284 Москва, 2-й Боткинский пр-д, 3

 Khomyakov Vladimir Mikhailov 

  2nd Botkinskiy proezd, Moscow 125284 

https://orcid.org/0000-0001-5169-2199ЦвиркунВ. В.TsvirkunV. V.

Цвиркун Виктор Викторович

111123 Москва, Новогиреевская ул., 1, корп. 1

Tsvirkun Viktor Viktorovich 

 Build. 1, 1 Novogireevskaya St., Moscow 111123 

https://orcid.org/0000-0003-0010-5294ШишинК. В.ShishinK. V.

Шишин Кирилл Вячеславович

111123 Москва, Новогиреевская ул., 1, корп. 1

 Kirill Vyacheslavovich Shishin 

 Build. 1, 1 Novogireevskaya St., Moscow 111123 

ГБУЗ г. Москвы «Московский клинический научно-практический центр им. А. С. Логинова Департамента здравоохранения г. Москвы»РоссияA. S. Loginov Moscow Clinical Scientific Center, Moscow Healthcare DepartmentRussian FederationФГБУ «Научный медицинский исследовательский центр онкологии им. Н. Н. Блохина» Минздрава РоссииРоссияN. N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiRussian FederationФГБУ «Национальный медицинский исследовательский центр онкологии им. Н. Н. Петрова» Минздрава РоссииРоссияN. N. Petrov National Medical Research Center of Oncology, Ministry of Health of RussiaRussian FederationФГБУ «Северо-западный окружной научно-клинический центр им. Л. Г. Соколова ФМБА»РоссияL. G. Sokolov North-Western District Scientific and Clinical Center, Federal Medical and Biological AgencyRussian FederationОнкологический центр No 1 Городской клинической больницы имени С. С. Юдина Департамента здравоохранения города Москвы»РоссияOncology Center No. 1 of the City Clinical Hospital named after S. S. Yudin of the Moscow Department of HealthRussian FederationМосковский научно-исследовательский онкологический институт им. П. А. Герцена — филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава РоссииРоссияP. A. Hertsen Moscow Oncology Research Institute — branch of the National Medical Research Radiological Center, Ministry of Health of RussiaRussian Federation20250302202615482–90Copyright © Хатьков И.В., Васнев О.С., Израилов Р.Е., Калинин А.Е., Карачун А.М., Кащенко В.А., Кононец П.В., Лядов В.К., Матвейчук Д.А., Недолужко И.Ю., Семенов Н.Е., Стилиди И.С., Хомяков В.М., Цвиркун В.В., Шишин К.В., 20262026Хатьков И.В., Васнев О.С., Израилов Р.Е., Калинин А.Е., Карачун А.М., Кащенко В.А., Кононец П.В., Лядов В.К., Матвейчук Д.А., Недолужко И.Ю., Семенов Н.Е., Стилиди И.С., Хомяков В.М., Цвиркун В.В., Шишин К.В.Khatkov I.E., Vasnev O.S., Izrailov R.E., Kalinin A.E., Karachun A.M., Kashchenko V.A., Kononets P.V., Lyadov V.K., Matveychuk D.А., Nedoluzhko I.Y., Semenov N.E., Stilidi I.S., Khomyakov V.M., Tsvirkun V.V., Shishin K.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.malignanttumors.org/jour/article/view/1598

Российский консенсус по профилактике, диагностике и лечению рака желудка подготовлен по инициативе Московского клинического научного центра им А. С. Логинова ДЗМ по Дельфийской системе. Его целью явилась консолидация мнений отечественных специалистов по наиболее актуальным вопросам профилактики, скрининга, диагностики и лечения рака желудка. Междисциплинарный подход обеспечен участием ведущих гастроэнтерологов, онкологов и хирургов. В данной статье представлены ключевые нерешенные вопросы хирургического лечения рака желудка, а также позиции Российского консенсуса по ним.

The Russian consensus on prevention, diagnostic and treatment of gastric cancer was prepared on the initiative of the Moscow clinical scientific center named after A. S. Loginov on the Delphi method. Its aim was to clarify and consolidate the opinions of specialists on the most relevant issues of prevention, diagnosis and treatment of gastric cancer. An interdisciplinary approach was provided by the participation of leading gastroenterologists, oncologists and surgeons.

консенсусрак желудкахирургическое лечение рака желудкаconsensusgastric cancer surgical treatmentReferencesSmyth E.C., Verheij M., Allum W., et al; ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016;27(suppl 5):v38-v49. https://doi.org/10.1093/annonc/mdw350. PMID: 27664260Smyth E.C., Verheij M., Allum W., et al; ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016;27(suppl 5):v38-v49. https://doi.org/10.1093/annonc/mdw350. PMID: 27664260Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021;24(1):1–21. https://doi.org/10.1007/s10120-020-01042-yJapanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021;24(1):1–21. https://doi.org/10.1007/s10120-020-01042-yOncology., NCCN Clinical Practice Guideline in. Gastric Cancer. version 3.2020. Available at: https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdfOncology., NCCN Clinical Practice Guideline in. Gastric Cancer. version 3.2020. Available at: https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdfGuideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach. J Gastric Cancer. 2019;19(1):1–48. https://doi.org/10.5230/jgc.2019.19.e8. Epub 2019 Mar 19. Erratum in: J Gastric Cancer. 2019;19(3):372–373Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach. J Gastric Cancer. 2019;19(1):1–48. https://doi.org/10.5230/jgc.2019.19.e8. Epub 2019 Mar 19. Erratum in: J Gastric Cancer. 2019;19(3):372–373Yoshida K., Kodera Y., Kochi M, et al. Addition of docetaxel to oral fluoropyrimidine improves efficacy in patients with stage III gastric cancer: interim analysis of JACCRO GC-07, a randomized controlled trial. J Clin Oncol 2019;37(15):1296–1304. https://doi.org/10.1200/JCO.18.01138Yoshida K., Kodera Y., Kochi M, et al. Addition of docetaxel to oral fluoropyrimidine improves efficacy in patients with stage III gastric cancer: interim analysis of JACCRO GC-07, a randomized controlled trial. J Clin Oncol 2019;37(15):1296–1304. https://doi.org/10.1200/JCO.18.01138Sasako M., Sakuramoto S., Katai H., et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 2011;29(33):4387–93. https://doi.org/10.1200/JCO.2011.36.5908Sasako M., Sakuramoto S., Katai H., et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 2011;29(33):4387–93. https:// doi.org/10.1200/JCO.2011.36.5908Noh S.H., Park S.R., Yang H.-K., et al. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. Lancet Oncol 2014;15(12):1389–96. https://doi.org/10.1016/S1470-2045(14)70473-5Noh S.H., Park S.R., Yang H.-K., et al. Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. Lancet Oncol 2014;15(12):1389–96. https://doi.org/10.1016/S1470-2045(14)70473-5Van den Ende T., Ter Veer E., Machiels M., et al. The efficacy and safety of (neo) adjuvant therapy for gastric cancer: a network meta-analysis. Cancers (Basel) 2019;11(1):80. https://doi.org/10.3390/cancers11010080Van den Ende T., Ter Veer E., Machiels M., et al. The efficacy and safety of (neo) adjuvant therapy for gastric cancer: a network meta-analysis. Cancers (Basel) 2019;11(1):80. https://doi.org/10.3390/cancers11010080Давыдов М.И., Абдихакимов А.Н., Полоцкий Б.Е. К вопросу о роли хирургии в лечении местно-распространенного и диссеминированного рака желудка. Анналы хирургии. 2012;2:33–41.Davydov M.I., Abdihakimov A.N., Polozkiy B.E. To the question of the role of surgery in the treatment of locally advanced and metastatic gastric cancer. The annals of surgery 2012;2:33–41 (In Russ.)Mintziras I., Miligkos M., Wächter S., Manoharan J., Bartsch D.K. Palliative surgical bypass is superior to palliative endoscopic stenting in patients with malignant gastric outlet obstruction: systematic review and meta-analysis. Surg Endosc 2019;33(10):3153–3164. https://doi.org/10.1007/s00464-019-06955-zMintziras I., Miligkos M., Wächter S., Manoharan J., Bartsch D.K. Palliative surgical bypass is superior to palliative endoscopic stenting in patients with malignant gastric outlet obstruction: systematic review and meta-analysis. Surg Endosc 2019;33(10):3153–3164. https://doi.org/10.1007/s00464-019-06955-zJang S., Stevens T., Lopez R., Bhatt A., Vargo J.J. Superiority of gastrojejunostomy over endoscopic stenting for palliation of malignant gastric outlet obstruction. Clin Gastroenterol Hepatol 2019;17(7):1295–1302.e1. https://doi.org/10.1016/j.cgh.2018.10.042Jang S., Stevens T., Lopez R., Bhatt A., Vargo J.J. Superiority of gastrojejunostomy over endoscopic stenting for palliation of malignant gastric outlet obstruction. Clin Gastroenterol Hepatol 2019;17(7):1295–1302.e1. https://doi.org/10.1016/j.cgh.2018.10.042Jeurnink S.M., Steyerberg E.W., Vleggaar F.P., et al; Dutch SUSTENT Study Group. Predictors of survival in patients with malignant gastric outlet obstruction: a patient-oriented decision approach for palliative treatment. Dig Liver Dis 2011;43(7):548–52. https://doi.org/10.1016/j.dld.2011.01.017Jeurnink S.M., Steyerberg E.W., Vleggaar F.P., et al; Dutch SUSTENT Study Group. Predictors of survival in patients with malignant gastric outlet obstruction: a patient-oriented decision approach for palliative treatment. Dig Liver Dis 2011;43(7):548–52. https://doi.org/10.1016/j.dld.2011.01.017Navarra G., Musolino C., Venneri A., De Marco M.L., Bartolotta M. Palliative antecolic isoperistaltic gastrojejunostomy: a randomized controlled trial comparing open and laparoscopic approaches. Surg Endosc 2006;20(12):1831–4. https://doi.org/10.1007/s00464-005-0454-5Navarra G., Musolino C., Venneri A., De Marco M.L., Bartolotta M. Palliative antecolic isoperistaltic gastrojejunostomy: a randomized controlled trial comparing open and laparoscopic approaches. Surg Endosc 2006;20(12):1831–4. https://doi.org/10.1007/s00464-005-0454-5Kumagai K., Rouvelas I., Ernberg A., et al. A systematic review and meta-analysis comparing partial stomach partitioning gastrojejunostomy versus conventional gastrojejunostomy for malignant gastroduodenal obstruction. Langenbecks Arch Surg 2016;401(6):777–85. https://doi.org/10.1007/s00423-016-1470-8Kumagai K., Rouvelas I., Ernberg A., et al. A systematic review and meta-analysis comparing partial stomach partitioning gastrojejunostomy versus conventional gastrojejunostomy for malignant gastroduodenal obstruction. Langenbecks Arch Surg 2016;401(6):777–85. https://doi.org/10.1007/s00423-016-1470-8Lorusso D., Giliberti A., Bianco M., Lantone G., Leandro G. Stomach-partitioning gastrojejunostomy is better than conventional gastrojejunostomy in palliative care of gastric outlet obstruction for gastric or pancreatic cancer: a meta-analysis. J Gastrointest Oncol 2019;10(2):283–291. https://doi.org/10.21037/jgo.2018.10.10Lorusso D., Giliberti A., Bianco M., Lantone G., Leandro G. Stomach-partitioning gastrojejunostomy is better than conventional gastrojejunostomy in palliative care of gastric outlet obstruction for gastric or pancreatic cancer: a meta-analysis. J Gastrointest Oncol 2019;10(2):283–291. https://doi.org/10.21037/jgo.2018.10.10Kim H.H., Hyung W.J., Cho G.S., et al. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report—a phase III multicenter, prospective, randomized Trial (KLASS Trial). Ann Surg 2010;251:417–20. https://doi.org/10.1097/SLA.0b013e3181cc8f6bKim H.H., Hyung W.J., Cho G.S., et al. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report—a phase III multicenter, prospective, randomized Trial (KLASS Trial). Ann Surg 2010;251:417–20. https://doi.org/10.1097/SLA.0b013e3181cc8f6bQiu H., Zhou Z. [Updates and interpretation on NCCN clinical practice guidelines for gastric cancer 2017 version 5]. Zhonghua Wei Chang Wai Ke Za Zhi. 2018;21(2):160–164Qiu H., Zhou Z. [Updates and interpretation on NCCN clinical practice guidelines for gastric cancer 2017 version 5]. Zhonghua Wei Chang Wai Ke Za Zhi. 2018;21(2):160–164Katai H., Mizusawa J., Katayama H., et al; Stomach Cancer Study Group of Japan Clinical Oncology Group. Single-arm confirmatory trial of laparoscopy-assisted total or proximal gastrectomy with nodal dissection for clinical stage I gastric cancer: Japan Clinical Oncology Group study JCOG1401. Gastric Cancer 2019;22(5):999–1008. https://doi.org/10.1007/s10120-019-00929-9Katai H., Mizusawa J., Katayama H., et al; Stomach Cancer Study Group of Japan Clinical Oncology Group. Single-arm confirmatory trial of laparoscopy-assisted total or proximal gastrectomy with nodal dissection for clinical stage I gastric cancer: Japan Clinical Oncology Group study JCOG1401. Gastric Cancer 2019;22(5):999–1008. https://doi.org/10.1007/s10120-019-00929-9Oh Y., Kim M.S., Lee Y.T., et al. Laparoscopic total gastrectomy as a valid procedure to treat gastric cancer option both in early and advanced stage: A systematic review and meta-analysis. Eur J Surg Oncol 2020;46(1):33–43. https://doi.org/10.1016/j.ejso.2019.08.018Oh Y., Kim M.S., Lee Y.T., et al. Laparoscopic total gastrectomy as a valid procedure to treat gastric cancer option both in early and advanced stage: A systematic review and meta-analysis. Eur J Surg Oncol 2020;46(1):33–43. https:// doi.org/10.1016/j.ejso.2019.08.018Haverkamp L., Brenkman H.J., Seesing M.F., et al; LOGICA study group. Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial). BMC Cancer 2015;15:556. https://doi.org/10.1186/s12885-015-1551-zHaverkamp L., Brenkman H.J., Seesing M.F., et al; LOGICA study group. Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial). BMC Cancer 2015;15:556. https://doi.org/10.1186/s12885-015-1551-zКарачун А.М., Пелипась Ю.В., Сапронов П.А., Козлов О.А., Асадчая Д.П. Проспективное нерандомизированное исследование по типу «случай контроль»: непосредственные результаты радикальных лапароскопических вмешательств при раке желудка, опыт одного центра. Вопросы онкологии 2017;63(2):247–255. https://doi.org/10.37469/0507-3758-2017-63-2-247-255.Karachun А.М., Pelipas Yu.V., Sapronov P.А., Kozlov O.А., Asadchaya D.P. Prospective non-randomized case-control study: immediate results of radical laparoscopic interventions for gastric cancer, the experience of a single center. Voprosy Onkologii = Problems in Oncology 2017;63(2):247–255. https://doi.org/10.37469/0507-3758-2017-63-2-247-255 (In Russ.)Израилов Р.Е., Поморцев Б.А., Хатьков И.Е., и соавт. Проспективное многоцентровое исследование по оценке эффективности лапароскопических гастрэктомий у больных с местно-распространенными формами рака желудка. Эндоскопическая хирургия. 2019;25(5):10–17. https://doi.org/10.17116/endoskop20192505110.Izrailov R.E., Pomortsev B.A., Khat’kov I.E., et al. Effectiveness of laparoscopic gastrectomy in patients with locally advanced gastric cancer: a prospective, multicenter study. Endoscopic Surgery. 2019;25(5):10–17 (In Russ.). https://doi.org/10.17116/endoskop20192505110Сажин И.В., Куликов Е.П., Сажин В.П. Открытая и лапароскопическая лимфаденэктомия в хирургическом лечении рака желудка. Хирургия. Журнал им. Н.И. Пирогова 2009;12:68–73Сажин И.В., Куликов Е.П., Сажин В.П. Открытая и лапароскопическая лимфаденэктомия в хирургическом лечении рака желудка. Хирургия. Журнал им. Н.И. Пирогова 2009;12:68–73Kodera Y., Yoshida K., Kumamaru H., et al. Introducing laparoscopic total gastrectomy for gastric cancer in general practice: a retrospective cohort study based on a nationwide registry database in Japan. Gastric Cancer 2019;22(1):202– 213. https://doi.org/10.1007/s10120-018-0795-0Kodera Y., Yoshida K., Kumamaru H., et al. Introducing laparoscopic total gastrectomy for gastric cancer in general practice: a retrospective cohort study based on a nationwide registry database in Japan. Gastric Cancer 2019;22(1):202– 213. https://doi.org/10.1007/s10120-018-0795-0Best L.M., Mughal M., Gurusamy K.S. Laparoscopic versus open gastrectomy for gastric cancer. Cochrane Database Syst Rev. 2016;3(3):CD011389. https://doi.org/10.1002/14651858.CD011389.pub2Best L.M., Mughal M., Gurusamy K.S. Laparoscopic versus open gastrectomy for gastric cancer. Cochrane Database Syst Rev. 2016;3(3):CD011389. https://doi.org/10.1002/14651858.CD011389.pub2Beyer K., Baukloh A.K., Kamphues C., et al. Laparoscopic versus open gastrectomy for locally advanced gastric cancer: a systematic review and meta-analysis of randomized controlled studies. World J Surg Oncol 2019;17(1):68. https://doi.org/10.1186/s12957-019-1600-1Beyer K., Baukloh A.K., Kamphues C., et al. Laparoscopic versus open gastrectomy for locally advanced gastric cancer: a systematic review and meta-analysis of randomized controlled studies. World J Surg Oncol 2019;17(1):68. https://doi.org/10.1186/s12957-019-1600-1Wang S.Y., Yeh C.N., Lee H.L., et al. Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy. Ann Surg Oncol 2009;16(10):2738–43. https://doi.org/10.1245/s10434-009-0616-0Wang S.Y., Yeh C.N., Lee H.L., et al. Clinical impact of positive surgical margin status on gastric cancer patients undergoing gastrectomy. Ann Surg Oncol 2009;16(10):2738–43. https://doi.org/10.1245/s10434-009-0616-0Kumazu Y., Hayashi T., Yoshikawa T., et al. Risk factors analysis and stratification for microscopically positive resection margin in gastric cancer patients. BMC Surg 2020;20(1):95. https://doi.org/10.1186/s12893-020-00744-5Kumazu Y., Hayashi T., Yoshikawa T., et al. Risk factors analysis and stratification for microscopically positive resection margin in gastric cancer patients. BMC Surg 2020;20(1):95. https://doi.org/10.1186/s12893-020-00744-5Jung K., Park M.I., Kim S.E., Park S.J. Borrmann type 4 advanced gastric cancer: focus on the development of scirrhous gastric cancer. Clin Endosc 2016;49(4):336–45. https://doi.org/10.5946/ce.2016.057Jung K., Park M.I., Kim S.E., Park S.J. Borrmann type 4 advanced gastric cancer: focus on the development of scirrhous gastric cancer. Clin Endosc 2016;49(4):336–45. https://doi.org/10.5946/ce.2016.057Mocellin S., Pasquali S. Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. Cochrane Database Syst Rev 2015;2015(2):CD009944. https://doi.org/10.1002/14651858.CD009944.pub2Mocellin S., Pasquali S. Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. Cochrane Database Syst Rev 2015;2015(2):CD009944. https://doi.org/10.1002/14651858.CD009944.pub2Fujitani K., Yang H.K., Mizusawa J., et al; REGATTA study investigators. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol 2016;17(3):309–318. https://doi.org/10.1016/S1470-2045(15)00553-7Fujitani K., Yang H.K., Mizusawa J., et al; REGATTA study investigators. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol 2016;17(3):309–318. https://doi.org/10.1016/S1470-2045(15)00553-7Al-Batran S.E., Homann N., Pauligk C., et al. Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: the AIO-FLOT3 trial. JAMA Oncol 2017;3(9):1237–1244. https://doi.org/10.1001/jamaoncol.2017.0515Al-Batran S.E., Homann N., Pauligk C., et al. Effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction cancer: the AIO-FLOT3 trial. JAMA Oncol 2017;3(9):1237–1244. https://doi.org/10.1001/jamaoncol.2017.0515Al-Batran S.E., Goetze T.O., Mueller D.W., et al. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI. BMC Cancer 2017;17(1):893. https://doi.org/10.1186/s12885-017-3918-9Al-Batran S.E., Goetze T.O., Mueller D.W., et al. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI. BMC Cancer 2017;17(1):893. https://doi.org/10.1186/s12885-017-3918-9Клинические рекомендации. Рак желудка, 2020. Доступно по: https://cr.minzdrav.gov.ru/preview-cr/574_1.Clinical Guidelines. Stomach cancer, 2020. Available at: https://cr.minzdrav.gov.ru/preview-cr/574_1 (In Russ.)Saiura A., Umekita N., Inoue S., et al. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer. Hepatogastroenterology 2002;49(46):1062–5Saiura A., Umekita N., Inoue S., et al. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer. Hepatogastroenterology 2002;49(46):1062–5D’Angelica M., Gonen M., Brennan M.F., et al. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 2004;240(5):808–16. https://doi.org/10.1097/01.sla.0000143245.28656.15D’Angelica M., Gonen M., Brennan M.F., et al. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 2004;240(5):808–16. https://doi.org/10.1097/01.sla.0000143245.28656.15Yamada Y., Higuchi K., Nishikawa K., et al. Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer. Ann Oncol 2015;26(1):141–148. https://doi.org/10.1093/annonc/mdu472Yamada Y., Higuchi K., Nishikawa K., et al. Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer. Ann Oncol 2015;26(1):141–148. https://doi.org/10.1093/annonc/mdu472Bang Y.J., Van Cutsem E., Feyereislova A., et al; ToGA Trial Investigators. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010;376(9742):687–97. https://doi.org/10.1016/S0140-6736(10)61121-X. Erratum in: Lancet 2010;376(9749):1302Bang Y.J., Van Cutsem E., Feyereislova A., et al; ToGA Trial Investigators. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010;376(9742):687–97. https://doi.org/10.1016/S0140-6736(10)61121-X. Erratum in: Lancet 2010;376(9749):1302Uggeri F., Ripamonti L., Pinotti E., et al. Is there a role for treatment-oriented surgery in liver metastases from gastric cancer? World J Clin Oncol 2020;11(7):477–494. https://doi.org/10.5306/wjco.v11.i7.477Uggeri F., Ripamonti L., Pinotti E., et al. Is there a role for treatment-oriented surgery in liver metastases from gastric cancer? World J Clin Oncol 2020;11(7):477–494. https://doi.org/10.5306/wjco.v11.i7.477Kinoshita T., Kinoshita T., Saiura A., et al. Multicentre analysis of long-term outcome after surgical resection for gastric cancer liver metastases. Br J Surg 2015;102(1):102–7. https://doi.org/10.1002/bjs.9684Kinoshita T., Kinoshita T., Saiura A., et al. Multicentre analysis of long-term outcome after surgical resection for gastric cancer liver metastases. Br J Surg 2015;102(1):102–7. https://doi.org/10.1002/bjs.9684Luo Z., Rong Z., Huang C. Surgery strategies for gastric cancer with liver metastasis. Front Oncol 2019;9:1353. https://doi.org/10.3389/fonc.2019.01353Luo Z., Rong Z., Huang C. Surgery strategies for gastric cancer with liver metastasis. Front Oncol 2019;9:1353. https://doi.org/10.3389/fonc.2019.01353Zhang K., Chen L. Chinese consensus on the diagnosis and treatment of gastric cancer with liver metastases. Ther Adv Med Oncol 2020;12:1758835920904803. https://doi.org/10.1177/1758835920904803Zhang K., Chen L. Chinese consensus on the diagnosis and treatment of gastric cancer with liver metastases. Ther Adv Med Oncol 2020;12:1758835920904803. https://doi.org/10.1177/1758835920904803Chung I.K., Lee J.H., Lee S.H., et al. Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. Gastrointest Endosc 2009;69(7):1228–35. https://doi.org/10.1016/j.gie.2008.09.027Chung I.K., Lee J.H., Lee S.H., et al. Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. Gastrointest Endosc 2009;69(7):1228–35. https://doi.org/10.1016/j.gie.2008.09.027Gotoda T., Jung H.Y. Endoscopic resection (endoscopic mucosal resection/ endoscopic submucosal dissection) for early gastric cancer. Dig Endosc 2013;25(Suppl_1):55–63. https://doi.org/10.1111/den.12003Gotoda T., Jung H.Y. Endoscopic resection (endoscopic mucosal resection/ endoscopic submucosal dissection) for early gastric cancer. Dig Endosc 2013;25(Suppl_1):55–63. https://doi.org/10.1111/den.12003Lian J., Chen S., Zhang Y., Qiu F. A meta-analysis of endoscopic submucosal dissection and EMR for early gastric cancer. Gastrointest Endosc 2012;76(4):763–70. https://doi.org/10.1016/j.gie.2012.06.014Lian J., Chen S., Zhang Y., Qiu F. A meta-analysis of endoscopic submucosal dissection and EMR for early gastric cancer. Gastrointest Endosc 2012;76(4):763–70. https://doi.org/10.1016/j.gie.2012.06.014Park Y.M., Cho E., Kang H.Y., Kim J.M. The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis. Surg Endosc 2011;25(8):2666–77. https://doi.org/10.1007/s00464-011-1627-zPark Y.M., Cho E., Kang H.Y., Kim J.M. The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis. Surg Endosc 2011;25(8):2666–77. https://doi.org/10.1007/s00464-011-1627-zGotoda T., Iwasaki M., Kusano C., Seewald S., Oda I. Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria. Br J Surg 2010;97(6):868–71. https://doi.org/10.1002/bjs.7033. PMID: 20301163Gotoda T., Iwasaki M., Kusano C., Seewald S., Oda I. Endoscopic resection of early gastric cancer treated by guideline and expanded National Cancer Centre criteria. Br J Surg 2010;97(6):868–71. https://doi.org/10.1002/bjs.7033. PMID: 20301163Gotoda T., Yanagisawa A., Sasako M., et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 2000;3(4):219–225. https://doi.org/10.1007/pl00011720Gotoda T., Yanagisawa A., Sasako M., et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 2000;3(4):219–225. https://doi.org/10.1007/pl00011720Ahn J.Y., Jung H.Y., Choi K.D., et al. Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications. Gastrointest Endosc 2011;74(3):485–93. https://doi.org/10.1016/j.gie.2011.04.038Ahn J.Y., Jung H.Y., Choi K.D., et al. Endoscopic and oncologic outcomes after endoscopic resection for early gastric cancer: 1370 cases of absolute and extended indications. Gastrointest Endosc 2011;74(3):485–93. https://doi.org/10.1016/j.gie.2011.04.038Кащенко В.А. Рак желудка: практические рекомендации / В.А. Кащенко, Р.В. Орлова. – СПб.: Изд-во “X-PRINT», 2014. – 60 с.Кащенко В.А. Рак желудка: практические рекомендации / В.А. Кащенко, Р.В. Орлова. – СПб.: Изд-во “X-PRINT», 2014. – 60 с.

The authors declare that there are no conflicts of interest present.